Daniel James Anthony Connolly

Daniel James Anthony Connolly

Auto-generated profile, based on publicly available information

Daniel James Anthony Connolly

Department of Neuroradiology, Royal Hallamshire Hospital, Sheffield, United Kingdom

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2007 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
ADA. A. Dawkins
A. A. Dawkins
AEA. L. Evans
A. L. Evans
JWJ. Wattam
J. Wattam
CRC. A. J. Romanowski
C. A. J. Romanowski
DCD. J. A. Connolly
D. J. A. Connolly
SCS. C. Coley
S. C. Coley

1 December 2013 in European Journal of Cancer
Verified
Journal Article
Open access
SBSimon Bailey
Simon Bailey
AHA. Howman
A. Howman
KWK. Wheatley
K. Wheatley
DWD. Wherton
D. Wherton
NBN. Boota
N. Boota
DHD. Hargrave
D. Hargrave
Diffuse intrinsic pontine glioma (DIPG) has a dismal prognosis with no chemotherapy regimen so far resulting in any significant improvement over standard radiotherapy. In this trial, a prolonged regimen (21/28d) of temozolomide was studied with the aim of overcoming O(6)-methylguanine methyltransferase (MGMT) mediated resistance. Forty-three patients with a defined clinico-radiological diagnosis of DIPG received radiotherapy and concomitant temozolomide (75 mg/m(2)) after which up to 12 courses of 21d of adjuvant temozolomide (75-100mg/m(2)) were given 4 weekly. The trial used a 2-stage design and passed interim analysis. At diagnosis median age was 8 years (2-20 years), 81% had cranial nerve abnormalities, 76% ataxia and 57% long tract signs. Median Karnofsky/Lansky score was 80 (10-100). Patients received a median of three courses of adjuvant temozolomide, five received all 12 courses and seven did not start adjuvant treatment. Three patients were withdrawn from study treatment due to haematological toxicity and 10 had a dose reduction. No other significant toxicity related to temozolomide was noted. Overall survival (OS) (95% confidence interval (CI)) was 56% (40%, 69%) at 9 months, 35% (21%, 49%) at 1 year and 17% (7%, 30%) at 2 years. Median survival was 9.5 months (range 7.5-11.4 months). There were five 2-year survivors with a median age of 13.6 years at diagnosis. This trial demonstrated no survival benefit of the addition of dose dense temozolomide, to standard radiotherapy in children with classical DIPG. However, a subgroup of adolescent DIPG patients did have a prolonged survival, which needs further exploration.

1 August 2010 in Postgraduate Medical Journal
Verified
Journal Article
Closed access
PDF file
DHD C Hughes
D C Hughes
ARA Raghavan
A Raghavan
SMS R Mordekar
S R Mordekar
PGP D Griffiths
P D Griffiths
DCD J A Connolly
D J A Connolly
Acute bacterial meningitis is a common neurological emergency and a leading cause of death and neurological disability worldwide. Diagnosis is based on clinical and microbiological findings with neuroimaging in the form of CT reserved for those with specific adverse clinical features or when an underlying cause such as mastoiditis is suspected. MRI is extremely useful for detecting and monitoring the complications of meningitis. These can be remembered by the mnemonic HACTIVE (hydrocephalus, abscess, cerebritis/cranial nerve lesion, thrombosis, infarct, ventriculitis/vasculopathy and extra-axial collection). Diffusion weighted imaging (DWI) and magnetic resonance spectroscopy (MRS) are useful to distinguish abscess from other ring enhancing lesions.

1 November 2001 in Clinical Radiology
Verified
Journal Article
Closed access
TMTom Meagher
Tom Meagher
VSV.P. Sukumar
V.P. Sukumar
JCJackie Collingwood
Jackie Collingwood
TCTherese Crawley
Therese Crawley
DSDavid Schofield
David Schofield
JGJohn Giles
John Giles

1 June 2011 in Pediatric Neurology
Verified
Journal Article
Closed access
SCStuart Currie
Stuart Currie
ARAshok Raghavan
Ashok Raghavan
RBRuth Batty
Ruth Batty
DCDaniel J.A. Connolly
Daniel J.A. Connolly
PGPaul D. Griffiths
Paul D. Griffiths

27 July 2012 in British Journal Of Neurosurgery
Verified
Journal Article
Closed access
ARAdam A. Razak
Adam A. Razak
MHMichelle Horridge
Michelle Horridge
DCDaniel J. Connolly
Daniel J. Connolly
DWDaniel J. Warren
Daniel J. Warren
SMShowkat Mirza
Showkat Mirza
SSSaurabh Sinha
Saurabh Sinha
Introduction. Pituitary surgery has seen a recent shift from a microscopic to an endoscopic trans-sphenoidal approach. We present our early experience with endoscopic surgery and compare the outcome with our recent microscopic experience. Methods. From January 2008 until present time, 80 consecutive patients underwent trans-sphenoidal pituitary surgery in our institution. Until September 2009, all patients had a microscopic trans-septal approach. After this time, the patients underwent endoscopic trans-sphenoidal surgery. All patients underwent pre- and post-operative MRI and full endocrinological evaluation. Data was collected prospectively including tumour volume, endocrine function, visual function, length of stay and complications. Results. There were 40 patients in each group. In the microscopic group, there were 26 non-functioning tumours and 14 functioning tumours. In the endoscopic group, there were 24 non-functioning and 16 functioning tumours. There were significantly better results in terms of tumour resection (p = 0.002) and remission (p = 0.018) in the endoscopic group. In this group there was also a lower incidence of CSF leaks and a shorter length of stay for secreting tumours (p = 0.005). 1 patient in the endoscopic group died at day 43 post-operatively, having initially presented in a poor clinical state with pituitary apoplexy. Conclusion. Microscopic trans-sphenoidal surgery remains the benchmark for future surgical techniques. Our early results suggest that endoscopic trans-sphenoidal surgery provides favourable results in both tumour resection and control of secreting tumours in comparison with microscopic surgery. Further longer-term evaluation is required to ensure the outcome of endoscopic surgery.